0
Back To Top Jump Location
Sign In  | Cart
Left Shadow
Right Shadow
State-of-the-art paper |

The Effects of Physical Activity on Serum C-Reactive Protein and Inflammatory Markers: A Systematic Review FREE

Christos Kasapis, MD; Paul D. Thompson, MD
[+] Author Information

Reprint requests and correspondence: Dr. Paul D. Thompson, Cardiology, Hartford Hospital, 80 Seymour Street, Hartford, Connecticut 06102

American College of Cardiology Foundation

J Am Coll Cardiol. 2005;45(10):1563-1569. doi:10.1016/j.jacc.2004.12.077
Published online

  Physical activity is associated with a reduced incidence of coronary disease, but the mechanisms mediating this effect are not defined. There has been considerable recent interest in inflammation in the pathogenesis of cardiovascular disease. Some of the beneficial role of physical activity may result from its effects on the inflammatory process. We searched PubMed for articles published between 1975 through May 2004 using the terms exercise, physical activity, or physical fitness combined with C-reactive protein, inflammation, inflammatory markers, or cytokines. The review revealed 19 articles on the acute inflammatory response to exercise, 18 on cross-sectional comparisons of subjects by activity levels, and 5 examining prospectively the effects of exercise training on the inflammatory process. Exercise produces a short-term, inflammatory response, whereas both cross-sectional comparisons and longitudinal exercise training studies demonstrate a long-term “anti-inflammatory” effect. This anti-inflammatory response may contribute to the beneficial effects of habitual physical activity.

Figures in this Article
APR

acute phase response

BMI

body mass index

CK

creatine kinase

CRP

high-sensitivity C-reactive protein

IL

interleukin

NHANES

National Health and Nutrition Examination Survey

PRINCE

Pravastatin Inflammation/CRP Evaluation study

TNF

tumor necrosis factor

There is increasing evidence that inflammation contributes to the atherosclerotic process (1). Several cytokines and acute-phase reactants have been examined as predictors of disease. High-sensitivity C-reactive protein (CRP) has the analyte and assay characteristics that are most conducive for clinical use and has shown a dose-response relationship to coronary heart disease that is independent of other major risk factors (2). Several roles have been postulated for CRP, including binding to phospholipids of damaged cells to activate complement and enhance uptake of these cells by macrophages, as well as activating endothelial cells to express adhesion molecules and decreasing the expression and bioavailability of endothelial nitric oxide synthase (35).

It is well documented that physical activity has a role in preventing coronary heart disease (6), mediated, in part, by changes in inflammation. This review examines the effects of physical activity on serum CRP and explores possible underlying mechanisms.

English-language articles on CRP and exercise published between 1975 and May 2004 were identified via a PubMed search and from references in other articles using the terms exercise, physical activity, or physical fitness in sequence with the terms CRP, inflammation, inflammatory markers, or cytokines. Articles examining the effects of exercise on CRP and inflammation were examined. The review identified 19 articles on the acute inflammatory response to exercise, 18 cross-sectional comparisons of subjects by activity levels, and 5 prospective studies of exercise training and the inflammatory process.

Several studies have examined the APR to strenuous exercise (Table 1) (712). A study (7) of 70 male and 20 female runners demonstrated marked but transient increases in the white blood cell count (+160%, p < 0.01) and CRP (+2,000%, p < 0.01) immediately and 24 h after a 42-km marathon race. There also were significant increases in interleukin (IL)-1 (+48%, p < 0.01) and creatinine kinase (CK) (+800%, p < 0.01) 24 h after exercise, suggesting that cytokines and/or muscle injury contribute to the inflammatory response. Values returned to baseline two to six days after exercise. Another study (8) evaluated the hematologic and APRs of 18 athletes to 21 km of canoeing, 97 km of cycling, and 42 km of running. C-reactive protein increased 266% (p < 0.05) 24 h after the race and returned to baseline by 48 h. There were parallel increases after the race in cortisol (+195%), white cell count (+158%), lactoferrin (+100%), and CK (+1,200%) (p < 0.05, for all). A study (9) of 55 runners in the 1996 and 1997 Boston marathons noted increases in CRP (+122%), fibrinolytic activity (+184%), von Willebrand factor (+113%), and D-dimer (+199%) within 4 h after the event (p < 0.001 for all).

Table Grahic Jump Location
Table 1Studies of Serum CRP After Strenuous Exercise
Table Footer NoteCRP in mg/l. CRP assay techniques account for the variation in values among studies. Maximum CRP was observed 24 to 48 h after exercise.
Table Footer NoteMaximum mean CRP after the 88-km race.

This APR to exercise seems to be proportional to the amount of activity and muscle injury. In 38 trained runners competing in races of 15 to 88 km, the APR, as assessed by CRP concentrations, increased with increasing race duration and serum CK levels (13). The APR also may be related to the type of exercise and the muscle mass involved. A study of 14 subjects found no increase in inflammatory markers after eccentric exercise using the elbow flexors, despite 100-fold increases in serum CK levels (14).

Exercise training appears to reduce the APR to strenuous activity. The APR to 2 h of running in three men was examined before and after nine weeks of endurance training (15). Post-run CRP, haptoglobin, and alpha-1 acid glycoprotein were reduced by 40%, 30%, and 60%, respectively, after training, although the distances that were run after training were 10%, 12%, and 20% longer.

The mechanisms mediating the APR to exercise are not defined. Interleukin-1, IL-6, and tumor necrosis factor (TNF)-alpha are involved in the APR. These cytokines, with the possible exception of TNF-alpha, temporarily increase during and shortly after prolonged exercise (1618). Interleukin-6 stimulates hepatic CRP synthesis and increases as much as 100-fold (1819) after strenuous exercise (1621). This increase in IL-6 is the earliest and most prominent of the cytokine responses to exercise (Figure 1) (21).

Grahic Jump Location
Figure 1

Plasma cytokine response to strenuous exercise. Adapted from Febbraio and Pedersen (21) with permission. IL = interleukin; IL-1ra = interleukin-1 receptor antagonist; MIP = macrophage inflammatory protein; TNF = tumor necrosis factor.

Exercise also produces an acute increase in various anti-inflammatory mediators, including the cytokine inhibitors, IL-1 receptor antagonist, TNF receptors, IL-10 and IL-8, and macrophage inflammatory proteins 1-alpha and -beta (1718,2122), whereas leukocyte adhesion molecules, such as beta-1 and -2 integrins, decrease (23). Thus, there is a parallel “protective” anti-inflammatory counter-regulation that also is part of the APR to exercise.

Exercise-induced muscle injury has been thought to be the primary stimulus for the IL-6 response. Recent studies suggest that complex intramuscular signaling stimulates the exercised muscle to release IL-6 (2021), independently of muscle damage. Subsequently, muscle damage per se elicits a repair response, including macrophage entry into the muscle, causing further IL-6 production. This injury-induced IL-6 response is delayed and smaller than the IL-6 production related to muscle contraction. This difference in injury versus contraction-induced IL-6 also may explain the observation that the IL-6 response is more pronounced, occurs earlier, and is shorter in duration after concentric compared with eccentric muscle contractions. During eccentric exercise, the muscle contracts while lengthening, producing greater muscle damage (20). Apart from the type of muscle contraction, the increase in IL-6 is directly related to exercise intensity, duration, and mass of muscle recruited (21). The role of muscle-derived IL-6 is under investigation, but it appears to act like a hormone, assisting glucose homeostasis and lipolysis during exercise, whereas it also may have immune regulatory effects by inhibiting TNF-alpha production (20,24).

Cross-sectional studies demonstrate an inverse relationship between regular physical activity and the serum concentration of inflammatory markers (Table 2). In the earliest report (25), baseline CRP levels in 356 male and 103 female athletes were compared with those from 45 male and 40 female untrained control subjects. Interestingly, in the athletes, the effects of exercise training on CRP varied with the type of exercise, and values were significantly lower than control subjects in swimmers (−80% for males and −72% for females, p < 0.001 for both) and rowers (−48%, p < 0.01 in males and −28%, but not significant in females), whereas in soccer players, CRP did not differ significantly from control subjects.

Table Grahic Jump Location
Table 2Cross-Sectional Studies on the Effects of Regular Physical Activity on Baseline Serum CRP
Table Footer NoteCRP in mg/l. CRP assay techniques account for the variation in values among studies.
Table Footer Note% participants with CRP >85th percentile.
Table Footer NoteSignificant only in ♂, but not in ♀ after adjustment.
Table Footer Note§% participants with CRP >7 mg/l.
Table Footer NoteBefore and
Table Footer Noteafter adjustment for confounding factors.
Table Footer Note⁎⁎p significant in Native American and Caucasian but not in African-American women.

The effects of various forms of exercise on inflammatory markers also were examined in 4,072 participants in the National Health and Nutrition Examination Survey (NHANES) III (26). Using bivariate analyses to compare different forms of exercise and after adjusting for confounding factors, joggers (odds ratio [OR] = 0.33) and aerobic dancers (OR = 0.31) were significantly less likely to have elevated inflammatory markers compared with cyclists (OR = 1.30), swimmers (OR = 0.62), and weightlifters (OR = 0.83). The amount of leisure-time physical activity also was inversely associated with CRP levels (p < 0.001) in 13,748 adults in NHANES III (27). This association remained significant after adjusting for such potential confounders as age, gender, ethnicity, education, occupation, smoking, hypertension, body mass index (BMI), waist-to-hip ratio, high-density lipoprotein cholesterol, aspirin use, chronic diseases affecting CRP, and serum insulin. Similarly, among 1,732 men and 1,101 women in the Pravastatin Inflammation/CRP Evaluation (PRINCE) study (28), strenuous aerobic activity was associated with lower CRP values in men after adjustment for confounders (p = 0.007) but not in women (p = 0.38). The reason for this gender-related discrepancy is unclear, but may be related to less physical activity in women.

Other cross-sectional studies (2936) also consistently demonstrate an inverse association between physical activity and CRP (Table 2). One of these studies (32) examined changes in physical activity over the course of 20 years and showed that inactive men who became active had CRP values approaching those of men who remained at least lightly active. Conversely, those who became inactive had CRP levels similar to those who remained inactive, suggesting that physical activity has to be continuous to maintain its effect on CRP, whereas taking up physical activity later in life can still alter CRP levels.

Two recent studies failed to confirm an independent inverse relationship between chronic physical activity and inflammation. In a longitudinal study (37) of 109 healthy men and women, BMI, but not current or previous-year physical activity, was significantly related to CRP. Similarly, a cross-sectional study (38) of 804 men found no relationship between leisure-time physical activity and CRP, fibrinogen, and serum amyloid A, after correction for BMI and current smoking status. One explanation for the absence of an exercise effect in these studies may be the high proportion of sedentary subjects. Also, physical activity remains an important correlate of CRP in multiple studies after adjustment for possible confounders, including BMI and smoking status (2633,3942).

Self-reported data, such as that cited in (Table 2), are subject to recall and reporting biases, which undermine the accurate classification of physical activity. To eliminate reporting bias, several studies examined the relationship of cardiorespiratory fitness to CRP. A cross-sectional survey (39) of 892 middle-aged men and women noted that cardiorespiratory fitness was inversely related to CRP levels in a stepwise fashion (p < 0.0001). For each 1-U increase in metabolic equivalents, the geometric mean of CRP decreased by 0.061 mg/l (95% confidence interval, 0.034 to 0.089 mg/l). This inverse relationship also has been observed in other studies after adjustment for potential confounders (4042). Among children and young adults (42), increased cardiorespiratory fitness was associated with decreased CRP levels in boys (r = −0.32, p < 0.01) but not in girls (r = −0.15, p = NS), again suggesting a different relationship between CRP and physical activity by gender (28,42).

Few studies have prospectively examined the effect of exercise training on CRP (Table 3). A randomized trial of 39 patients with intermittent claudication demonstrated that both CRP and serum amyloid-A levels were significantly reduced after three and six months of supervised exercise compared with controls (43). Similarly, nine months of marathon training (n = 12) reduced CRP levels by 31% (p < 0.05) versus no change in non-training control subjects (n = 10) (44). A 35%, albeit nonsignificant, reduction in CRP also was observed among 43 subjects at high risk of ischemic heart disease after six months of supervised exercise training (45). These prospective intervention trials support the concept that exercise training reduces CRP levels by altering the inflammatory process.

Table Grahic Jump Location
Table 3Prospective Studies of Physical Training and Serum CRP
Table Footer NoteCRP in mg/l. CRP assay techniques account for the variation in values among studies.
Table Footer NotePatients with intermittent claudication.
Table Footer NoteSignificant only for the exercise group.

How exercise training reduces inflammation and suppresses CRP levels is not well defined. Physical activity is related to several confounders that are independently associated with lower CRP levels. For example, physical activity is inversely related to age, smoking, hypertension, BMI, and waist-to-hip ratio, total and non-high-density lipoprotein cholesterol, triglycerides, and apolipoprotein B concentrations, whereas these factors are directly related to CRP concentrations (27). Similarly, physical activity is directly related to the proportion of white participants, education level, insulin sensitivity, alcohol consumption, and fruit and vegetable intake, all factors that are inversely associated with CRP (27). Despite the overlap between factors associated with physical activity and CRP, higher CRP levels persist in more active subjects in most studies even after adjustment.

Hepatic CRP production is stimulated by IL-6 and, to a lesser extent, by IL-1 and TNF-alpha. Individuals who are obese and/or hyperinsulinemic have increased adipocyte production of inflammatory markers, including CRP, IL-6, and TNF-alpha (4647). A multidisciplinary program to reduce body weight in obese women through lifestyle changes, including a low-calorie diet, and increased physical activity, reduced IL-6, IL-18, CRP, and insulin resistance, whereas adiponectin levels increased (48). Adiponectin is a novel adipocytokine with anti-inflammatory and insulin-sensitizing properties (49). Evidence also exists that leptin levels are reduced in physically active individuals independent of BMI (33) and that leptin is associated with CRP (50). Moreover, in centrally obese individuals, omental adipocytes produce more IL-6 than do abdominal subcutaneous adipocytes (51). Consequently, physical activity could decrease resting levels of IL-6 and TNF-alpha and, ultimately, CRP production, by reducing obesity and leptin and increasing adiponectin and insulin sensitivity (52). Once again, however, the relationship between increased physical activity and lower CRP persists even after adjusting for BMI, waist-to-hip ratio, and fasting insulin concentration (2633,3942), suggesting that other factors contribute to the exercise-related anti-inflammatory effect.

Some of this effect may be mediated by modification of cytokine production from other sites, besides adipose tissue, such as skeletal muscles (53) and mononuclear cells (45). Exercise training reduces skeletal muscle TNF-alpha, IL-1-beta, and IL-6 expression in patients with heart failure (53). Furthermore, long-term exercise attenuates mononuclear cell production of atherogenic cytokines (IL-1-alpha, TNF-alpha, and interferon gamma) while augmenting the production of atheroprotective cytokines (IL-4, IL-10, and transforming growth factor-beta-1) (45). Thus, these multifocal effects of exercise drive the resting cytokine balance to an “anti-inflammatory” state.

Physical activity may also mitigate inflammation by improving endothelial function. Endothelial cells are known to secrete IL-1 and IL-6, whereas activated endothelial cells can increase the production of ILs and adhesion molecules inducing inflammation (54). Physical training reduces peripheral inflammatory markers associated with endothelial dysfunction, such as soluble intracellular and vascular adhesion molecules, granulocyte-macrophage colony-stimulating factor, and macrophage chemoattractant protein-1 in patients with heart failure (55). Regular physical activity also improves endothelial function preserving nitric oxide availability (56). Although exercise acutely increases oxidative metabolism and thereby induces oxidative stress, there is evidence that long-term physical activity increases antioxidant defenses through the up-regulation of antioxidant enzymes (57). Furthermore, this antioxidant effect of exercise reduces the susceptibility of low-density lipoprotein to oxidation (58), which in turn helps further prevent endothelial injury and inflammation (5960). In summary, it is likely that exercise training reduces CRP both directly by reducing cytokine production in fat, muscle, and mononuclear cells and indirectly by increasing insulin sensitivity, improving endothelial function, and reducing body weight.

Acute effects of strenuous exercise

Most of the studies demonstrating that exercise transiently increases the APR have examined trained athletes. Only one study of three untrained subjects indicates that exercise training blunts the APR (15). Further prospective studies are needed to evaluate the APR in previously untrained subjects after training. The effect of genetic variability on the APR and on the effects of exercise training also warrants examination. A recent report examined the influence of the +1444C>T variant of the human CRP gene on CRP and its response to physical activity in 250 army recruits (61). Subjects homozygous for the +1444TT gene had higher baseline CRP and a greater increase after physical activity than did carriers of the C-allele. Larger study cohorts, including women, are needed to confirm these findings.

Chronic effects of physical activity

C-reactive protein levels are consistently lower in cross-sectional studies (Table 2). Only three small prospective studies (4345) have demonstrated a reduction in CRP with the initiation of physical activity. Further prospective randomized studies of exercise and inflammation are needed. Additionally, future research is necessary to delineate the mechanisms by which physical activity affects the inflammatory process.

Conclusions

There is a short-term, transient increase in serum CRP after strenuous exercise, produced by an exercise-induced APR, mediated by the cytokine system and mainly IL-6. Exercise training may blunt this response, whereas there is also a homeostatic, anti-inflammatory counter-APR after strenuous exercise. Chronic physical activity reduces resting CRP levels by multiple mechanisms, including a decrease in cytokine production by adipose tissue, skeletal muscles, endothelial and blood mononuclear cells, improved endothelial function and insulin sensitivity, and possibly an antioxidant effect.

Ross  R.; Atherosclerosis—an inflammatory disease. N Engl J Med. 340 1999:115-126.
CrossRef | PubMed
Pearson  T.A., Mensah  G.A., Alexander  R.W.; Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation. 107 2003:499-511.
CrossRef | PubMed
Lagrand  W.K., Visser  C.A., Hermens  W.T.; C-reactive protein as a cardiovascular risk factor. more than an epiphenomenon?. Circulation. 100 1999:96-102.
CrossRef | PubMed
Pasceri  V., Willerson  J.T., Yeh  E.T.; Direct proinflammatory effect of C-reactive protein on human endothelial cells. Circulation. 102 2000:2165-2168.
CrossRef | PubMed
Verma  S., Wang  C.H., Li  S.H.; A self-fulfilling prophecy. C-reactive protein attenuates nitric oxide production and inhibits angiogenesis. Circulation. 106 2002:913-919.
CrossRef | PubMed
Fletcher  G.F., Balady  G.J., Amsterdam  E.A.; Exercise standards for testing and training. a statement for healthcare professionals from the American Heart Association. Circulation. 104 2001:1694-1740.
CrossRef | PubMed
Weight  L.M., Alexander  D., Jacobs  P.; Strenuous exercise. analogous to the acute-phase response?. Clin Sci (Lond). 81 1991:677-683.
PubMed
Taylor  C., Rogers  G., Goodman  C.; Hematologic, iron-related, and acute-phase protein responses to sustained strenuous exercise. J Appl Physiol. 62 1987:464-469.
PubMed
Siegel  A.J., Stec  J.J., Lipinska  I.; Effect of marathon running on inflammatory and hemostatic markers. Am J Cardiol. 88 2001:918-920.
CrossRef | PubMed
Fallon  K.E.; The acute phase response and exercise. the ultramarathon as prototype exercise. Clin J Sport Med. 11 2001:38-43.
CrossRef | PubMed
Castell  L.M., Poortmans  J.R., Leclercq  R., Brasseur  M., Duchateau  J., Newsholme  E.A.; Some aspects of the acute phase response after a marathon race, and the effects of glutamine supplementation. Eur J Appl Physiol Occup Physiol. 75 1997:47-53.
CrossRef | PubMed
Drenth  J.P., Krebbers  R.J., Bijzet  J., van der Meer  J.W.; Increased circulating cytokine receptors and ex vivo interleukin-1 receptor antagonist and interleukin-1beta production but decreased tumour necrosis factor-alpha production after a 5-km run. Eur J Clin Invest. 28 1998:866-872.
CrossRef | PubMed
Strachan  A.F., Noakes  T.D., Kotzenberg  G., Nel  A.E., de Beer  F.C.; C reactive protein concentrations during long distance running. Br Med J. 289 1984:1249-1251.
CrossRef
Nosaka  K., Clarkson  P.M.; Changes in indicators of inflammation after eccentric exercise of the elbow flexors. Med Sci Sports Exerc. 28 1996:953-961.
PubMed
Liesen  H., Dufaux  B., Hollmann  W.; Modifications of serum glycoproteins the days following a prolonged physical exercise and the influence of physical training. Eur J Appl Physiol Occup Physiol. 37 1977:243-254.
CrossRef | PubMed
Pedersen  B.K., Hoffman-Goetz  L.; Exercise and the immune system. regulation, integration, and adaptation. Physiol Rev. 80 2000:1055-1081.
PubMed
Ostrowski  K., Hermann  C., Bangash  A., Schjerling  P., Nielsen  J.N., Pedersen  B.K.; A trauma-like elevation of plasma cytokines in humans in response to treadmill running. J Physiol. 513 1998:889-894.
CrossRef | PubMed
Ostrowski  K., Rohde  T., Asp  S., Schjerling  P., Pedersen  B.K.; Pro- and anti-inflammatory cytokine balance in strenuous exercise in humans. J Physiol. 515 1999:287-291.
CrossRef | PubMed
Ostrowski  K., Rohde  T., Zacho  M., Asp  S., Pedersen  B.K.; Evidence that interleukin-6 is produced in human skeletal muscle during prolonged running. J Physiol. 508 1998:949-953.
CrossRef | PubMed
Pedersen  B.K., Steensberg  A., Schjerling  P.; Muscle-derived interleukin-6. possible biological effects. J Physiol. 536 2001:329-337.
CrossRef | PubMed
Febbraio  M.A., Pedersen  B.K.; Muscle-derived interleukin-6. mechanisms for activation and possible biological roles. FASEB J. 16 2002:1335-1347.
CrossRef | PubMed
Ostrowski  K., Rohde  T., Asp  S., Schjerling  P., Pedersen  B.K.; Chemokines are elevated in plasma after strenuous exercise in humans. Eur J Appl Physiol. 84 2001:244-245.
CrossRef | PubMed
Jordan  J., Beneke  R., Hutler  M., Veith  A., Haller  H., Luft  F.C.; Moderate exercise leads to decreased expression of beta1 and beta2 integrins on leucocytes. Eur J Appl Physiol Occup Physiol. 76 1997:192-194.
CrossRef | PubMed
Pedersen  B.K., Steensberg  A., Keller  P.; Muscle-derived interleukin-6. lipolytic, anti-inflammatory and immune regulatory effects. Pflugers Arch. 446 2003:9-16.
PubMed
Dufaux  B., Order  U., Geyer  H., Hollmann  W.; C-reactive protein serum concentrations in well-trained athletes. Int J Sports Med. 5 1984:102-106.
CrossRef | PubMed
King  D.E., Carek  P., Mainous  A.G.  III, Pearson  W.S.; Inflammatory markers and exercise. differences related to exercise type. Med Sci Sports Exerc. 35 2003:575-581.
CrossRef | PubMed
Ford  E.S.; Does exercise reduce inflammation? Physical activity and C-reactive protein among U.S. adults. Epidemiology. 13 2002:561-568.
CrossRef | PubMed
Albert  M.A., Glynn  R.J., Ridker  P.M.; Effect of physical activity on serum C-reactive protein. Am J Cardiol. 93 2004:221-225.
CrossRef | PubMed
Abramson  J.L., Vaccarino  V.; Relationship between physical activity and inflammation among apparently healthy middle-aged and older U.S. adults. Arch Intern Med. 162 2002:1286-1292.
CrossRef | PubMed
Geffken  D.F., Cushman  M., Burke  G.L., Polak  J.F., Sakkinen  P.A., Tracy  R.P.; Association between physical activity and markers of inflammation in a healthy elderly population. Am J Epidemiol. 153 2001:242-250.
CrossRef | PubMed
Taaffe  D.R., Harris  T.B., Ferrucci  L., Rowe  J., Seeman  T.E.; Cross-sectional and prospective relationships of interleukin-6 and C-reactive protein with physical performance in elderly persons. MacArthur studies of successful aging. J Gerontol A Biol Sci Med Sci. 55 2000:M709-M715.
CrossRef | PubMed
Wannamethee  S.G., Lowe  G.D., Whincup  P.H., Rumley  A., Walker  M., Lennon  L.; Physical activity and hemostatic and inflammatory variables in elderly men. Circulation. 105 2002:1785-1790.
CrossRef | PubMed
Tomaszewski  M., Charchar  F.J., Przybycin  M.; Strikingly low circulating CRP concentrations in ultramarathon runners independent of markers of adiposity. how low can you go?. Arterioscler Thromb Vasc Biol. 23 2003:1640-1644.
CrossRef | PubMed
Koenig  W., Sund  M., Frohlich  M.; C-Reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men. results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984 to 1992. Circulation. 99 1999:237-242.
CrossRef | PubMed
Pitsavos  C., Chrysohoou  C., Panagiotakos  D.B.; Association of leisure-time physical activity on inflammation markers (C-reactive protein, white cell blood count, serum amyloid A, and fibrinogen) in healthy subjects (from the ATTICA study). Am J Cardiol. 91 2003:368-370.
CrossRef | PubMed
Rohde  L.E., Hennekens  C.H., Ridker  P.M.; Survey of C-reactive protein and cardiovascular risk factors in apparently healthy men. Am J Cardiol. 84 1999:1018-1022.
CrossRef | PubMed
Rawson  E.S., Freedson  P.S., Osganian  S.K., Matthews  C.E., Reed  G., Ockene  I.S.; Body mass index, but not physical activity, is associated with C-reactive protein. Med Sci Sports Exerc. 35 2003:1160-1166.
CrossRef | PubMed
Verdaet  D., Dendale  P., De Bacquer  D., Delanghe  J., Block  P., De Backer  G.; Association between leisure time physical activity and markers of inflammation related to coronary heart disease. Atherosclerosis. 176 2004:303-310.
CrossRef | PubMed
Aronson  D., Sheikh-Ahmad  M., Avizohar  O.; C-Reactive protein is inversely related to physical fitness in middle-aged subjects. Atherosclerosis. 176 2004:173-179.
CrossRef | PubMed
Church  T.S., Barlow  C.E., Earnest  C.P., Kampert  J.B., Priest  E.L., Blair  S.N.; Associations between cardiorespiratory fitness and C-reactive protein in men. Arterioscler Thromb Vasc Biol. 22 2002:1869-1876.
CrossRef | PubMed
LaMonte  M.J., Durstine  J.L., Yanowitz  F.G.; Cardiorespiratory fitness and C-reactive protein among a tri-ethnic sample of women. Circulation. 106 2002:403-406.
CrossRef | PubMed
Isasi  C.R., Deckelbaum  R.J., Tracy  R.P., Starc  T.J., Berglund  L., Shea  S.; Physical fitness and C-reactive protein level in children and young adults. the Columbia University BioMarkers Study. Pediatrics. 111 2003:332-338.
CrossRef | PubMed
Tisi  P.V., Hulse  M., Chulakadabba  A., Gosling  P., Shearman  C.P.; Exercise training for intermittent claudication. does it adversely affect biochemical markers of the exercise-induced inflammatory response?. Eur J Vasc Endovasc Surg. 14 1997:344-350.
CrossRef | PubMed
Mattusch  F., Dufaux  B., Heine  O., Mertens  I., Rost  R.; Reduction of the plasma concentration of C-reactive protein following nine months of endurance training. Int J Sports Med. 21 2000:21-24.
CrossRef | PubMed
Smith  J.K., Dykes  R., Douglas  J.E., Krishnaswamy  G., Berk  S.; Long-term exercise and atherogenic activity of blood mononuclear cells in persons at risk of developing ischemic heart disease. JAMA. 281 1999:1722-1727.
CrossRef | PubMed
McLaughlin  T., Abbasi  F., Lamendola  C.; Differentiation between obesity and insulin resistance in the association with C-reactive protein. Circulation. 106 2002:2908-2912.
CrossRef | PubMed
Yudkin  J.S., Stehouwer  C.D., Emeis  J.J., Coppack  S.W.; C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue?. Arterioscler Thromb Vasc Biol. 19 1999:972-978.
CrossRef | PubMed
Esposito  K., Pontillo  A., Di Palo  C.; Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women. a randomized trial. JAMA. 289 2003:1799-1804.
CrossRef | PubMed
Stefan  N., Stumvoll  M.; Adiponectin—its role in metabolism and beyond. Horm Metab Res. 34 2002:469-474.
CrossRef | PubMed
Shamsuzzaman  A.S., Winnicki  M., Wolk  R.; Independent association between plasma leptin and C-reactive protein in healthy humans. Circulation. 109 2004:2181-2185.
CrossRef | PubMed
Fried  S.K., Bunkin  D.A., Greenberg  A.S.; Omental and subcutaneous adipose tissues of obese subjects release interleukin-6. depot difference and regulation by glucocorticoid. J Clin Endocrinol Metab. 83 1998:847-850.
CrossRef | PubMed
Mayer-Davis  E.J., D’Agostino  R.  Jr., Karter  A.J.; Intensity and amount of physical activity in relation to insulin sensitivity. the Insulin Resistance Atherosclerosis Study. JAMA. 279 1998:669-674.
CrossRef | PubMed
Gielen  S., Adams  V., Mobius-Winkler  S.; Anti-inflammatory effects of exercise training in the skeletal muscle of patients with chronic heart failure. J Am Coll Cardiol. 42 2003:861-868.
CrossRef | PubMed
Romano  M., Sironi  M., Toniatti  C.; Role of IL-6 and its soluble receptor in induction of chemokines and leukocyte recruitment. Immunity. 6 1997:315-325.
CrossRef | PubMed
Adamopoulos  S., Parissis  J., Kroupis  C.; Physical training reduces peripheral markers of inflammation in patients with chronic heart failure. Eur Heart J. 22 2001:791-797.
CrossRef | PubMed
Taddei  S., Galetta  F., Virdis  A.; Physical activity prevents age-related impairment in nitric oxide availability in elderly athletes. Circulation. 101 2000:2896-2901.
CrossRef | PubMed
Powers  S.K., Ji  L.L., Leeuwenburgh  C.; Exercise training-induced alterations in skeletal muscle antioxidant capacity. a brief review. Med Sci Sports Exerc. 31 1999:987-997.
CrossRef | PubMed
Shern-Brewer  R., Santanam  N., Wetzstein  C., White-Welkley  J., Parthasarathy  S.; Exercise and cardiovascular disease. a new perspective. Arterioscler Thromb Vasc Biol. 18 1998:1181-1187.
CrossRef | PubMed
Witztum  J.L.; Immunological response to oxidized LDL. Atherosclerosis. 131 (Suppl) 1997:S9-S11.
CrossRef | PubMed
Berliner  J.A., Navab  M., Fogelman  A.M.; Atherosclerosis: basic mechanisms. Oxidation, inflammation, and genetics. Circulation. 91 1995:2488-2496.
CrossRef | PubMed
Brull  D.J., Serrano  N., Zito  F.; Human CRP gene polymorphism influences CRP levels. implications for the prediction and pathogenesis of coronary heart disease. Arterioscler Thromb Vasc Biol. 23 2003:2063-2069.
CrossRef | PubMed

Figures

Grahic Jump Location
Figure 1

Plasma cytokine response to strenuous exercise. Adapted from Febbraio and Pedersen (21) with permission. IL = interleukin; IL-1ra = interleukin-1 receptor antagonist; MIP = macrophage inflammatory protein; TNF = tumor necrosis factor.

Tables

Table Grahic Jump Location
Table 1Studies of Serum CRP After Strenuous Exercise
Table Footer NoteCRP in mg/l. CRP assay techniques account for the variation in values among studies. Maximum CRP was observed 24 to 48 h after exercise.
Table Footer NoteMaximum mean CRP after the 88-km race.
Table Grahic Jump Location
Table 2Cross-Sectional Studies on the Effects of Regular Physical Activity on Baseline Serum CRP
Table Footer NoteCRP in mg/l. CRP assay techniques account for the variation in values among studies.
Table Footer Note% participants with CRP >85th percentile.
Table Footer NoteSignificant only in ♂, but not in ♀ after adjustment.
Table Footer Note§% participants with CRP >7 mg/l.
Table Footer NoteBefore and
Table Footer Noteafter adjustment for confounding factors.
Table Footer Note⁎⁎p significant in Native American and Caucasian but not in African-American women.
Table Grahic Jump Location
Table 3Prospective Studies of Physical Training and Serum CRP
Table Footer NoteCRP in mg/l. CRP assay techniques account for the variation in values among studies.
Table Footer NotePatients with intermittent claudication.
Table Footer NoteSignificant only for the exercise group.

Interactive Graphics

Video

References

Ross  R.; Atherosclerosis—an inflammatory disease. N Engl J Med. 340 1999:115-126.
CrossRef | PubMed
Pearson  T.A., Mensah  G.A., Alexander  R.W.; Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation. 107 2003:499-511.
CrossRef | PubMed
Lagrand  W.K., Visser  C.A., Hermens  W.T.; C-reactive protein as a cardiovascular risk factor. more than an epiphenomenon?. Circulation. 100 1999:96-102.
CrossRef | PubMed
Pasceri  V., Willerson  J.T., Yeh  E.T.; Direct proinflammatory effect of C-reactive protein on human endothelial cells. Circulation. 102 2000:2165-2168.
CrossRef | PubMed
Verma  S., Wang  C.H., Li  S.H.; A self-fulfilling prophecy. C-reactive protein attenuates nitric oxide production and inhibits angiogenesis. Circulation. 106 2002:913-919.
CrossRef | PubMed
Fletcher  G.F., Balady  G.J., Amsterdam  E.A.; Exercise standards for testing and training. a statement for healthcare professionals from the American Heart Association. Circulation. 104 2001:1694-1740.
CrossRef | PubMed
Weight  L.M., Alexander  D., Jacobs  P.; Strenuous exercise. analogous to the acute-phase response?. Clin Sci (Lond). 81 1991:677-683.
PubMed
Taylor  C., Rogers  G., Goodman  C.; Hematologic, iron-related, and acute-phase protein responses to sustained strenuous exercise. J Appl Physiol. 62 1987:464-469.
PubMed
Siegel  A.J., Stec  J.J., Lipinska  I.; Effect of marathon running on inflammatory and hemostatic markers. Am J Cardiol. 88 2001:918-920.
CrossRef | PubMed
Fallon  K.E.; The acute phase response and exercise. the ultramarathon as prototype exercise. Clin J Sport Med. 11 2001:38-43.
CrossRef | PubMed
Castell  L.M., Poortmans  J.R., Leclercq  R., Brasseur  M., Duchateau  J., Newsholme  E.A.; Some aspects of the acute phase response after a marathon race, and the effects of glutamine supplementation. Eur J Appl Physiol Occup Physiol. 75 1997:47-53.
CrossRef | PubMed
Drenth  J.P., Krebbers  R.J., Bijzet  J., van der Meer  J.W.; Increased circulating cytokine receptors and ex vivo interleukin-1 receptor antagonist and interleukin-1beta production but decreased tumour necrosis factor-alpha production after a 5-km run. Eur J Clin Invest. 28 1998:866-872.
CrossRef | PubMed
Strachan  A.F., Noakes  T.D., Kotzenberg  G., Nel  A.E., de Beer  F.C.; C reactive protein concentrations during long distance running. Br Med J. 289 1984:1249-1251.
CrossRef
Nosaka  K., Clarkson  P.M.; Changes in indicators of inflammation after eccentric exercise of the elbow flexors. Med Sci Sports Exerc. 28 1996:953-961.
PubMed
Liesen  H., Dufaux  B., Hollmann  W.; Modifications of serum glycoproteins the days following a prolonged physical exercise and the influence of physical training. Eur J Appl Physiol Occup Physiol. 37 1977:243-254.
CrossRef | PubMed
Pedersen  B.K., Hoffman-Goetz  L.; Exercise and the immune system. regulation, integration, and adaptation. Physiol Rev. 80 2000:1055-1081.
PubMed
Ostrowski  K., Hermann  C., Bangash  A., Schjerling  P., Nielsen  J.N., Pedersen  B.K.; A trauma-like elevation of plasma cytokines in humans in response to treadmill running. J Physiol. 513 1998:889-894.
CrossRef | PubMed
Ostrowski  K., Rohde  T., Asp  S., Schjerling  P., Pedersen  B.K.; Pro- and anti-inflammatory cytokine balance in strenuous exercise in humans. J Physiol. 515 1999:287-291.
CrossRef | PubMed
Ostrowski  K., Rohde  T., Zacho  M., Asp  S., Pedersen  B.K.; Evidence that interleukin-6 is produced in human skeletal muscle during prolonged running. J Physiol. 508 1998:949-953.
CrossRef | PubMed
Pedersen  B.K., Steensberg  A., Schjerling  P.; Muscle-derived interleukin-6. possible biological effects. J Physiol. 536 2001:329-337.
CrossRef | PubMed
Febbraio  M.A., Pedersen  B.K.; Muscle-derived interleukin-6. mechanisms for activation and possible biological roles. FASEB J. 16 2002:1335-1347.
CrossRef | PubMed
Ostrowski  K., Rohde  T., Asp  S., Schjerling  P., Pedersen  B.K.; Chemokines are elevated in plasma after strenuous exercise in humans. Eur J Appl Physiol. 84 2001:244-245.
CrossRef | PubMed
Jordan  J., Beneke  R., Hutler  M., Veith  A., Haller  H., Luft  F.C.; Moderate exercise leads to decreased expression of beta1 and beta2 integrins on leucocytes. Eur J Appl Physiol Occup Physiol. 76 1997:192-194.
CrossRef | PubMed
Pedersen  B.K., Steensberg  A., Keller  P.; Muscle-derived interleukin-6. lipolytic, anti-inflammatory and immune regulatory effects. Pflugers Arch. 446 2003:9-16.
PubMed
Dufaux  B., Order  U., Geyer  H., Hollmann  W.; C-reactive protein serum concentrations in well-trained athletes. Int J Sports Med. 5 1984:102-106.
CrossRef | PubMed
King  D.E., Carek  P., Mainous  A.G.  III, Pearson  W.S.; Inflammatory markers and exercise. differences related to exercise type. Med Sci Sports Exerc. 35 2003:575-581.
CrossRef | PubMed
Ford  E.S.; Does exercise reduce inflammation? Physical activity and C-reactive protein among U.S. adults. Epidemiology. 13 2002:561-568.
CrossRef | PubMed
Albert  M.A., Glynn  R.J., Ridker  P.M.; Effect of physical activity on serum C-reactive protein. Am J Cardiol. 93 2004:221-225.
CrossRef | PubMed
Abramson  J.L., Vaccarino  V.; Relationship between physical activity and inflammation among apparently healthy middle-aged and older U.S. adults. Arch Intern Med. 162 2002:1286-1292.
CrossRef | PubMed
Geffken  D.F., Cushman  M., Burke  G.L., Polak  J.F., Sakkinen  P.A., Tracy  R.P.; Association between physical activity and markers of inflammation in a healthy elderly population. Am J Epidemiol. 153 2001:242-250.
CrossRef | PubMed
Taaffe  D.R., Harris  T.B., Ferrucci  L., Rowe  J., Seeman  T.E.; Cross-sectional and prospective relationships of interleukin-6 and C-reactive protein with physical performance in elderly persons. MacArthur studies of successful aging. J Gerontol A Biol Sci Med Sci. 55 2000:M709-M715.
CrossRef | PubMed
Wannamethee  S.G., Lowe  G.D., Whincup  P.H., Rumley  A., Walker  M., Lennon  L.; Physical activity and hemostatic and inflammatory variables in elderly men. Circulation. 105 2002:1785-1790.
CrossRef | PubMed
Tomaszewski  M., Charchar  F.J., Przybycin  M.; Strikingly low circulating CRP concentrations in ultramarathon runners independent of markers of adiposity. how low can you go?. Arterioscler Thromb Vasc Biol. 23 2003:1640-1644.
CrossRef | PubMed
Koenig  W., Sund  M., Frohlich  M.; C-Reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men. results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984 to 1992. Circulation. 99 1999:237-242.
CrossRef | PubMed
Pitsavos  C., Chrysohoou  C., Panagiotakos  D.B.; Association of leisure-time physical activity on inflammation markers (C-reactive protein, white cell blood count, serum amyloid A, and fibrinogen) in healthy subjects (from the ATTICA study). Am J Cardiol. 91 2003:368-370.
CrossRef | PubMed
Rohde  L.E., Hennekens  C.H., Ridker  P.M.; Survey of C-reactive protein and cardiovascular risk factors in apparently healthy men. Am J Cardiol. 84 1999:1018-1022.
CrossRef | PubMed
Rawson  E.S., Freedson  P.S., Osganian  S.K., Matthews  C.E., Reed  G., Ockene  I.S.; Body mass index, but not physical activity, is associated with C-reactive protein. Med Sci Sports Exerc. 35 2003:1160-1166.
CrossRef | PubMed
Verdaet  D., Dendale  P., De Bacquer  D., Delanghe  J., Block  P., De Backer  G.; Association between leisure time physical activity and markers of inflammation related to coronary heart disease. Atherosclerosis. 176 2004:303-310.
CrossRef | PubMed
Aronson  D., Sheikh-Ahmad  M., Avizohar  O.; C-Reactive protein is inversely related to physical fitness in middle-aged subjects. Atherosclerosis. 176 2004:173-179.
CrossRef | PubMed
Church  T.S., Barlow  C.E., Earnest  C.P., Kampert  J.B., Priest  E.L., Blair  S.N.; Associations between cardiorespiratory fitness and C-reactive protein in men. Arterioscler Thromb Vasc Biol. 22 2002:1869-1876.
CrossRef | PubMed
LaMonte  M.J., Durstine  J.L., Yanowitz  F.G.; Cardiorespiratory fitness and C-reactive protein among a tri-ethnic sample of women. Circulation. 106 2002:403-406.
CrossRef | PubMed
Isasi  C.R., Deckelbaum  R.J., Tracy  R.P., Starc  T.J., Berglund  L., Shea  S.; Physical fitness and C-reactive protein level in children and young adults. the Columbia University BioMarkers Study. Pediatrics. 111 2003:332-338.
CrossRef | PubMed
Tisi  P.V., Hulse  M., Chulakadabba  A., Gosling  P., Shearman  C.P.; Exercise training for intermittent claudication. does it adversely affect biochemical markers of the exercise-induced inflammatory response?. Eur J Vasc Endovasc Surg. 14 1997:344-350.
CrossRef | PubMed
Mattusch  F., Dufaux  B., Heine  O., Mertens  I., Rost  R.; Reduction of the plasma concentration of C-reactive protein following nine months of endurance training. Int J Sports Med. 21 2000:21-24.
CrossRef | PubMed
Smith  J.K., Dykes  R., Douglas  J.E., Krishnaswamy  G., Berk  S.; Long-term exercise and atherogenic activity of blood mononuclear cells in persons at risk of developing ischemic heart disease. JAMA. 281 1999:1722-1727.
CrossRef | PubMed
McLaughlin  T., Abbasi  F., Lamendola  C.; Differentiation between obesity and insulin resistance in the association with C-reactive protein. Circulation. 106 2002:2908-2912.
CrossRef | PubMed
Yudkin  J.S., Stehouwer  C.D., Emeis  J.J., Coppack  S.W.; C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue?. Arterioscler Thromb Vasc Biol. 19 1999:972-978.
CrossRef | PubMed
Esposito  K., Pontillo  A., Di Palo  C.; Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women. a randomized trial. JAMA. 289 2003:1799-1804.
CrossRef | PubMed
Stefan  N., Stumvoll  M.; Adiponectin—its role in metabolism and beyond. Horm Metab Res. 34 2002:469-474.
CrossRef | PubMed
Shamsuzzaman  A.S., Winnicki  M., Wolk  R.; Independent association between plasma leptin and C-reactive protein in healthy humans. Circulation. 109 2004:2181-2185.
CrossRef | PubMed
Fried  S.K., Bunkin  D.A., Greenberg  A.S.; Omental and subcutaneous adipose tissues of obese subjects release interleukin-6. depot difference and regulation by glucocorticoid. J Clin Endocrinol Metab. 83 1998:847-850.
CrossRef | PubMed
Mayer-Davis  E.J., D’Agostino  R.  Jr., Karter  A.J.; Intensity and amount of physical activity in relation to insulin sensitivity. the Insulin Resistance Atherosclerosis Study. JAMA. 279 1998:669-674.
CrossRef | PubMed
Gielen  S., Adams  V., Mobius-Winkler  S.; Anti-inflammatory effects of exercise training in the skeletal muscle of patients with chronic heart failure. J Am Coll Cardiol. 42 2003:861-868.
CrossRef | PubMed
Romano  M., Sironi  M., Toniatti  C.; Role of IL-6 and its soluble receptor in induction of chemokines and leukocyte recruitment. Immunity. 6 1997:315-325.
CrossRef | PubMed
Adamopoulos  S., Parissis  J., Kroupis  C.; Physical training reduces peripheral markers of inflammation in patients with chronic heart failure. Eur Heart J. 22 2001:791-797.
CrossRef | PubMed
Taddei  S., Galetta  F., Virdis  A.; Physical activity prevents age-related impairment in nitric oxide availability in elderly athletes. Circulation. 101 2000:2896-2901.
CrossRef | PubMed
Powers  S.K., Ji  L.L., Leeuwenburgh  C.; Exercise training-induced alterations in skeletal muscle antioxidant capacity. a brief review. Med Sci Sports Exerc. 31 1999:987-997.
CrossRef | PubMed
Shern-Brewer  R., Santanam  N., Wetzstein  C., White-Welkley  J., Parthasarathy  S.; Exercise and cardiovascular disease. a new perspective. Arterioscler Thromb Vasc Biol. 18 1998:1181-1187.
CrossRef | PubMed
Witztum  J.L.; Immunological response to oxidized LDL. Atherosclerosis. 131 (Suppl) 1997:S9-S11.
CrossRef | PubMed
Berliner  J.A., Navab  M., Fogelman  A.M.; Atherosclerosis: basic mechanisms. Oxidation, inflammation, and genetics. Circulation. 91 1995:2488-2496.
CrossRef | PubMed
Brull  D.J., Serrano  N., Zito  F.; Human CRP gene polymorphism influences CRP levels. implications for the prediction and pathogenesis of coronary heart disease. Arterioscler Thromb Vasc Biol. 23 2003:2063-2069.
CrossRef | PubMed

Correspondence

Latest JACC CME

Continuing Medical Education through JACC is a convenient way to fulfill your CME requirements while learning important information about the latest advances in cardiovascular medicine.

April 2013- JACC CME Activity
Repeat Revascularization and Outcome

March 2013- JACC CME Activity
Extreme Lipoprotein(a) Levels and Improved Cardiovascular Risk Prediction

Feb 2013- JACC CME Activity
Results from the BARI 2D Trial

Jan 2013- JACC CME Activity
Prognosis Among Healthy Individuals Discharged With a Primary Diagnosis of Syncope

Dec 2012- JACC CME Activity
Incidence of Heart Failure or Cardiomyopathy After Adjuvant Trastuzumab Therapy for Breast Cancer

Nov 2012- JACC CME Activity
A Collaborative Analysis of Individual Patient Data From 10 Randomized Trials

Oct 2012- JACC CME Activity
Radiofrequency Ablation of Premature Ventricular Ectopy Improves the Efficacy of Cardiac Resynchronization Therapy in Nonresponders

Sept 2012- JACC CME Activity
Exercise and Pharmacological Treatment of Depressive Symptoms in Patients With Coronary Heart Disease

Aug 2012- JACC CME Activity
Reduction in Life-Threatening Ventricular Tachyarrhythmias in Statin-Treated Patients With Nonischemic Cardiomyopathy Enrolled in the MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy)

July 2012- JACC CME Activity
Relationship of Beta-Blocker Dose With Outcomes in Ambulatory Heart Failure Patients With Systolic Dysfunction

For previous CME quizzes, please follow this link to CardioSource Lifelong Learning and MOC.

 

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s “Cited By” API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Comment
Submit a Comment

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Topics
PubMed Articles